← SynDRA
BAFETINIB
SynDRA canonical compound SYN0006131 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ABL1 | BCR | FYN | LYN |
| Mechanism of action | Bcr-Abl kinase inhibitor | LYN tyrosine kinase inhibitor |
All known targets
- LYN
- ABL1
- BCR
- BCR-ABL1
- FYN
Mechanisms of action (all sources)
- ABL1 INHIBITOR
- Tyrosine-protein kinase ABL inhibitor
- LYN INHIBITOR
- Tyrosine-protein kinase Lyn inhibitor
- Bcr-Abl kinase inhibitor
- LYN tyrosine kinase inhibitor
- LYN MODULATOR
- Modulator
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- BAFETINIB (INNO-406)
- CNS-9
- INNO-406
- LYN-IN-1
- NS-187
- INNO 406
- NS 187
- UNII-NVW4Z03I9B
- NVW4Z03I9B
- INNO406
- CHEMBL206834
- (S)-N-(3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide
- 4-[[(3S)-3-DIMETHYLAMINOPYRROLIDIN-1-YL]METHYL]-N-[4-METHYL-3-[(4-PYRIMIDIN-5-YLPYRIMIDIN-2-YL)AMINO]PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE
- N-[3-(4,5'-Bipyrimidin-2-Ylamino)-4-Methylphenyl]-4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]methyl}-3-(Trifluoromethyl)benzamide
- Bafetinib (USAN)
- BAFETINIB [USAN]
- Bafetinib [INN]
- Benzamide, N-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)-
- Bafetinib [USAN:INN]
- Bafetinib - INNO-406
- BAFETINIB [MART.]
- BAFETINIB [WHO-DD]
- GTPL7906
- SCHEMBL2684766
- DTXSID001006512
- BCP22045
- EX-A1534
- BDBM50178612
- NSC788186
- NSC799354
- s1369
- ZINC22940637
- CCG-270114
- CS-5142
- DB11851
- NSC-788186
- NSC-799354
- NCGC00386698-02
- NCGC00386698-03
Look up BAFETINIB in the interactive SynDRA portal →